logo
logo
STXS stock ticker logo

Stereotaxis, Inc.

AMEX•STXS
CEO: Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
セクター: Healthcare
業種: Medical - Instruments & Supplies
上場日: 2004-08-12
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
連絡先情報
710 North Tucker Boulevard, Suite 110, Saint Louis, MO, 63101, United States
314-678-6100
www.stereotaxis.com
時価総額
$175.45M
PER (TTM)
-8.3
14.1
配当利回り
--
52週高値
$3.59
52週安値
$1.54
52週レンジ
17%
順位58Top 85.6%
2.3
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 2.3 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$8.64M+0.00%
直近4四半期の推移

EPS

-$0.06+0.00%
直近4四半期の推移

フリーCF

-$4.04M+0.00%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Nine Months Revenue Growth Nine months total revenue reached $23.74M, increasing 15% driven by full year impact of acquired disposable sales.
Common Stockholder Loss Narrowed Net loss attributable to common stockholders narrowed to $17.07M, improving from $17.51M prior nine-month period.
Q3 Gross Margin Expansion Q3 Gross Margin rose to 55% from 45% last year, due to favorable shift in product mix towards disposables.
Financing Activities Provided Cash Secured $7.81M net cash from financing activities, primarily driven by July 2025 registered direct equity offering proceeds.

リスク要因

Macroeconomic and Supply Chain Macro factors, supply chain issues, and inflation continue to pressure operations, potentially impacting product availability.
G&A Expense Driven Higher G&A expenses rose 13% to $13.7M, primarily driven by contingent consideration revaluation expense recognized in earnings.
Fluid Global Tariff Environment Fluid global tariff environment, especially US-China, could materially affect cost structure and gross margins if reinstated.
Future Capital Needs Risk Existing cash may not suffice; future financing may be required, potentially dilutive to current common stockholders.

見通し

Advance Regulatory Adoption Plans to advance adoption of robotic systems in markets where regulatory clearance has been recently received or is pending.
Continued Operating Losses Expected Expect additional operating losses in remainder of 2025 while funding development, commercialization, and marketing initiatives.
APT Integration Focus Management focused on integrating APT business, minimizing complexity, and realizing strategic benefits post-acquisition completion.
ATM Program Funding Available $50.0M ATM Program remains available for working capital and accelerated commercialization pipeline funding needs.

同業比較

売上高 (TTM)

NEO stock ticker logoNEO
$727.33M
+10.1%
MDXH stock ticker logoMDXH
$159.60M
+19.8%
QTRX stock ticker logoQTRX
$138.73M
+2.4%

粗利益率 (最新四半期)

SMTI stock ticker logoSMTI
92.9%
+2.1pp
CVRX stock ticker logoCVRX
86.3%
+3.6pp
ARCT stock ticker logoARCT
77.9%
-19.5pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
OSUR$225.99M-3.2-18.6%3.3%
QTRX$223.43M-2.1-35.2%8.9%
NEO$207.18M-1.9-12.6%34.7%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
5.0%
緩やかな成長
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
0%
キャッシュフローに注意が必要

深度リサーチ

次回決算:2026年5月11日
|
EPS:-$0.05
|
売上高:$8.70M
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし